Performance Highlights

In the first half of 2025, the macroeconomic and geopolitical environment was fraught with challenges. The competitive advantages of the Group’s abundant medical resources and a large customer base helped us to withstand the adverse impacts of the operating environment. The Group has taken decisive cost control measures, including the elimination of unnecessary procedures, the simplification of organisational structure and the optimisation of workforce. These initiatives are aimed at improving operational effectiveness and efficiency, thereby enhancing overall competitiveness.

Despite the severe operating environment in the first half of 2025, there was no material adverse change in the Group’s operating performance. During the Period under review, the Group achieved turnaround from loss to profit, and recorded an unaudited profit of approximately HK$35.6 million (2024: loss of approximately HK$28.5 million), including an unaudited profit attributable to shareholders of approximately HK$12.7 million (2024: loss of approximately HK$47.7 million). If the “other gains and losses, net”, which comprise the gains and losses incurred outside the Group’s ordinary course of business, as shown in the condensed consolidated statement of profit or loss are excluded, the Group would have recorded an unaudited operating profit of approximately HK$38.9 million, including an unaudited operating profit attributable to shareholders of approximately HK$16.1 million with respect to its business operations for the Period under review. The Group is committed to the ongoing enhancement of its operational efficiency, particularly to meet the growing demand for value-for-money medical services. The Group demonstrated operational resilience and adaptability.

During the Period under review, the Group’s liquidity position was well-managed and the Group’s financial resources were sufficient to support its business operations. As at 30 June 2025, the Group had net assets of approximately HK$3,436.9 million, including net current assets of approximately HK$1,306.1 million. The Group had a current ratio (defined as total current assets divided by total current liabilities) of 3.19 and a gearing ratio (defined as total bank borrowings divided by equity attributable to owners of the Company) of 0.38% as at 30 June 2025.